Mansoor Raza Mirza, MD, on Reducing Toxicity Associated With PARP Inhibitors in Ovarian Cancer

Posted: Wednesday, July 3, 2019

Under what circumstances would you switch from one PARP inhibitor to a different one with the goal of reducing a side effect, such as nausea?